Scientific American reports on Population Council’s upcoming international clinical trial of a Nestorone®/Testosterone gel, a novel reversible contraceptive for men.
Today, there is widespread recognition that gender-based violence (GBV) is a human rights violation and pervasive global health challenge with many consequences for women and girls including physical injury, psychological trauma, unwanted pregnancy, and sexually transmitted infections, including HIV.
New York, NY (August 17, 2017) — The Population Council has been awarded Breakthrough-RESEARCH, a five-year cooperative agreement from the U.S. Agency for International Development (USAID). The project aims to improve healthy behaviors and norms across key global health areas, including family planning and reproductive health; HIV/AIDS; maternal, newborn and child health; emerging infectious diseases; and malaria. Led by the Population Council, consortium partners include the Institute for Reproductive Health at Georgetown University, Population Reference Bureau, Tulane University, Avenir Health and ideas42.
Each day, approximately 4600 people around the world are newly infected with HIV, and more than 2500 die of HIV related causes each year.1 Substantial progress has been made to combat the epidemic, but the need for rigorous research and scientific breakthrough to achieve an AIDS-free world has never been more pressing.
In an article rounding up highlights from the London Family Planning Summit, Devex speaks with Population Council president Julia Bunting about having a more diverse set of players at the table. She explains why translating energy into action will be crucial to accelerating progress towards the Family Planning 2020 goals.
In a widely syndicated op-ed, Population Council’s Thoai Ngo argues that empowering girls with knowledge and skills to participate in the 21st century economy is not just the right thing to do, but the smart thing to do for global development.